US Stock MarketDetailed Quotes

GYRE Gyre Therapeutics

Watchlist
  • 14.900
  • -0.340-2.23%
Trading Jul 24 11:05 ET
1.27BMarket Cap-14522P/E (TTM)

Gyre Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Business Currency:USD
2024/Q1
Stock NameRevenueRatio
Gyre Pharmaceuticals27.17M100.00%
Region Currency:USD
2023/FY
Stock NameRevenueRatio
United States113.45M100.00%

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg